Disposable income meets cloning science
Category: Culture of science
I'll let the Boston Herald News tell the tale: A celebrity from the moment he bounded off an American Airlines...
Posted by David Dobbs at 11:43 AM • 0 Comments • 0 TrackBacks
Neuron Culture
David Dobbs on science, nature, and culture.
Search
Profile
I write on science, medicine, nature, culture and other matters for the New York Times Magazine, The Atlantic, Slate, National Geographic, Scientific American Mind, and other publications. (Find clips here.) Right now I'm writing my fourth book, The Orchid and the Dandelion, which explores the hypothesis that the genetic roots some of our worst problems and traits — depresison, hyperaggression, violence, antisocial behavior — can also give rise to resilience, cooperation, empathy, and contentment. The book expands on my December 2009 Atlantic article exploring these ideas.
I've also written three books, including Reef Madness: Charles Darwin, Alexander Agassiz, and the Meaning of Coral, which traces the strangest but most forgotten controversy in Darwin's career — an elemental dispute running some 75 years.
If you'd like, you can subscribe to Neuron Culture by email. You might also want to see more of my work at my main website or check out my Tumblr log.
My Google Shared links
Recent Posts
- Top 5 Neuron Culture hits from January - plus Neil Young
- The mojo of open journalism, plus that itchy beta thing
- The Rise Of Marketing-Based Medicine (via Pharmalot)
- Hits of the week past
- Chess computing as a metaphor for Pharma. Who knew?
- Democrats Now See 'No Rush' on Health Care Bill
- Why do antidepressants work only for the deeply depressed? A neuroskeptical look
- Rice, alcohol, and really fast evolution in humans
- Ezra Klein - America spends way, way, way more on health care
- NEJM study finds post-event morphine cuts combat PTSD rates in half
Recent Comments
- Neuroskeptic on Why do antidepressants work only for the deeply depressed? A neuroskeptical look
- David Dobbs on The mojo of open journalism, plus that itchy beta thing
- Isis the Scientist on The mojo of open journalism, plus that itchy beta thing
- Ed Yong on The mojo of open journalism, plus that itchy beta thing
- John Timmer on The mojo of open journalism, plus that itchy beta thing
- JerryM on The mojo of open journalism, plus that itchy beta thing
- Coturnix on The mojo of open journalism, plus that itchy beta thing
- Arikia Millikan on The mojo of open journalism, plus that itchy beta thing
- feralboy12 on The Rise Of Marketing-Based Medicine (via Pharmalot)
- gillt on Rebooting science journalism, redux
Categories
- Art
- Books
- Brains and minds
- Culture of science
- Digital culture
- Economics
- Education
- Environment/nature
- Evolution
- Food and Drink
- Healthcare policy
- History/philosophy of science
- Interesting if true...
- Journalism
- Matters military
- Media
- Medicine
- Music
- Neuroethics
- Nota Bene
- Orchids & Dandelions (behav genetics)
- PTSD
- Pharma
- Politics
- Psychiatry
- Reading
- Science
- Science policy
- Sports
- Swine flu
- Writing
January 28, 2009
Updike's essays, and the Virginia Woolf test
Category: Books
It was wonderful, for instance, to see Updike, beginning in his late fifties, set out to make himself a deeply informed writer on art, which he did; most of that work ended up in the New York Review of Books.
Posted by David Dobbs at 6:12 AM • 0 Comments • 0 TrackBacks
Pfizer employee to new colleagues: Buckle up
Category: Pharma
Pharma giant Pfizer got bigger on Monday, purchasing Wyeth Pharamceuticals for $65 billion in one of the few big...
Posted by David Dobbs at 5:31 AM • 2 Comments • 0 TrackBacks
January 27, 2009
Jascha smokes some Mozart
Category: Brains and minds
's Mozart's birthday. We've been indulging in some Don Giovanni here amid (but inside, protected from) the snow. But for multimedia instead of fireside consumption, I thought this effortlessly electric encore by Heifetz would serve nicely.
Posted by David Dobbs at 9:09 PM • 0 Comments • 0 TrackBacks
Pfizer pays $2.3 billion off-label marketing fine
Category: Pharma
Close on the heels of Lilly's $1.42 billion penalty for off-label marketing comes the news that Pfizer paid out $2.3 billion to settle similar allegations.
Posted by David Dobbs at 9:05 PM • 0 Comments • 0 TrackBacks
Updike down
Category: Books
'Tis a smaller world now. John Updike is dead of lung cancer. The end of Rabbit at Rest: "Well,...
Posted by David Dobbs at 2:47 PM • 0 Comments • 0 TrackBacks
Your brain on football - it's not pretty
Category: Medicine
CNN has a fascinating and rather frightening story about the toll football (or the concussions acquired playing it) take on...
Posted by David Dobbs at 1:51 PM • 4 Comments • 0 TrackBacks
Why Frank Rich links
Category: Journalism
The Neiman Journalism Lab ponders the question:. : Why has Rich embraced linking when his peers have not? "CThe...
Posted by David Dobbs at 9:47 AM • 0 Comments • 0 TrackBacks
Twitter is f'in - or at least way -- cool
Category: Digital culture
I'm rapidly seeing that Twitter isn't all bad after all. I've little taste for it when used primarily as...
Posted by David Dobbs at 9:22 AM • 0 Comments • 0 TrackBacks
January 25, 2009
"How We Decide" - the thinking person's "Blink"
Category: Books
This is a rare book -- a serious but seriously fun work about the complicated process of thinking that is bright, lucid, and lively while still being true to the science. "How We Decide" is the thinking person's "Blink."
Posted by David Dobbs at 10:45 PM • 3 Comments • 0 TrackBacks
Previous
Next
